The following information is obtained from various newswires,
published medical journal articles, and medical conference presentations.
Company: Mallinckrodt Group
Approval Status: Approved August 1996
Treatment for: chronic pain
General Information
The UltraJect Morphine Sulfate Injection has been approved in two dosage strengths. It is the first terminally sterilized plastic syringe intended for use with patient-controlled pain management. The injection system allows patients to dispense their own medication. Morphine sulfate is used to treat moderate to severe pain such as that associated with post-operative surgical pain or cancer.
